The role of procalcitonin in febrile neutropenic patients: Review of the literature

Infection

Volumn 36, Issue 5, 2008, Pages 396-407

  Sakr, Y ^a   Sponholz, C ^a   Tuche, F ^a   Brunkhorst, F ^a   Reinhart, K ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTOXIN; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA;

BACTEREMIA; BACTERIAL INFECTION; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEBRILE NEUTROPENIA; GRAM NEGATIVE INFECTION; HUMAN; LEUKOCYTE COUNT; MICROBIAL IDENTIFICATION; MICROORGANISM DETECTION; MYCOSIS; NON INVASIVE MEASUREMENT; OUTCOME ASSESSMENT; PROGNOSIS; QUALITATIVE ANALYSIS; REVIEW; SEPSIS;

ADULT; BIOLOGICAL MARKERS; CALCITONIN; CHILD; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; HUMANS; INFANT; MALE; NEUTROPENIA; PROGNOSIS; PROTEIN PRECURSORS; UNITED STATES;

EID: 56549122800     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-008-7374-y     Document Type: Review

References (61)

1. Hughes WT, Armstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD, Pizzo PA, Schimpff SC, Shenep JL, Wade JC: From the Infectious Diseases Society of America: guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381-396.
2. Sharma A, Lokeshwar N: Febrile neutropenia in haematological malignancies. J Postgrad Med 2005; 51: S42-S48.
3. Petersdorf RG, Beeson PB: Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 1961; 40: 1-30.
4. Gaeta GB, Fusco FM, Nardiello S: Fever of unknown origin: a systematic review of the literature for 1995-2004. Nucl Med Commun 2006; 27: 205-211.
5. Durack DT, Street AC: Fever of unknown origin-reexamined and redefined. Curr Clin Top Infect Dis 1991; 11: 35-51.
6. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 2004; 39: 206-217.
7. Barnes C, Ignjatovic V, Newall F, Carlin J, Ng F, Hamilton S, Ashley D, Waters K, Monagle P: Change in serum procalcitonin (deltaPCT) predicts the clinical outcome of children admitted with febrile neutropenia. Br J Haematol 2002; 118: 1197-1198.
8. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R: Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 2000; 26: S148-S152.
9. Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Muller B: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 2004; 363: 600-607.
10. Sandek A, Springer J, Habedank D, Brunkhorst F, Anker SD: Procalcitonin-guided antibiotic treatment in heart failure. Lancet 2004; 363: 1555-1556.
11. Robinson JO, Calandra T, Marchetti O: Utility of procalcitonin for the diagnosis and the follow-up of infections in febrile neutropenic patients. Rev Med Suisse 2005; 1: 878-6.
12. Christ-Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, Zimmerli W, Harbarth S, Tamm M, Muller B: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 2006; 174: 84-93.
13. Oberhoffer M, Vogelsang H, Russwurm S, Hartung T, Reinhart K: Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 1999; 37: 363-368.
14. Luyt CE, Guerin V, Combes A, Trouillet JL, Ayed SB, Bernard M, Gibert C, Chastre J: Procalcitonin kinetics as a prognostic marker of ventilator- associated pneumonia. Am J Respir Crit Care Med 2005; 171: 48-53.
15. Oczenski W, Fitzgerald RD, Schwarz S: Procalcitonin: a new parameter for the diagnosis of bacterial infection in the perioperative period. Eur J Anaesthesiol 1998; 15: 202-209.
16. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003.
17. Muller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF: Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab 2001; 86: 396-404.
18. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, Limburg PC, ten Duis HJ, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH: Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit CareMed 2000; 28: 458-461.
19. Linscheid P, Seboek D, Nylen ES, Langer I, Schlatter M, Becker KL, Keller U, Muller B: In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue. Endocrinology 2003; 144: 5578-5584.
20. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Muller B: Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit Care Med 2004; 32: 1715-1721.
21. Russwurm S, Reinhart K: Procalcitonin mode of action: new pieces in a complex puzzle. Crit Care Med 2004; 32: 1801-1802.
22. Schwaner I, Fekardt KU: Procalcitonin concentrations during high dose therapy with autologous stem cell rescue (abstract). Deutsche und österreichische Gesellschaft für Hämatologie und Onkologie. LINZ 1997; 20:28.
23. Bernard L, Ferriere F, Casassus P, Malas F, Leveque S, Guillevin L, Lortholary O: Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin Infect Dis 1998; 27: 914-915.
24. Sauer M, Tiede K, Volland R, Fuchs D, Zintl F: Procalcitonin in comparison to C-reactive protein as markers of the course of sepsis in severely immunocompromised children after bone marrow transplantation. Klin Padiatr 2000; 212: 10-15.
25. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J: The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25.
26. Engel A, Steinbach G, Kern P, Kern WV: Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand J Infect Dis 1999; 31: 185-189.
27. Hambach L, Eder M, Dammann E, Schrauder A, Sykora KW, Dieterich C, Kirschner P, Novotny J, Ganser A, Hertenstein B: Diagnostic value of procalcitonin serum levels in comparison with C-reactive protein in allogeneic stem cell transplantation. Haematologica 2002; 87: 643-651.
28. Pihusch M, Pihusch R, Fraunberger P, Pihusch V, Andreesen R, Kolb HJ, Holler E: Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients. Eur J Haematol 2006; 76: 93-101.
29. Schuttrumpf S, Binder L, Hagemann T, Berkovic D, Trumper L, Binder C: Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations. Clin Infect Dis 2006; 43: 468-473.
30. Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P, Galani L, Anagnostopoulos N, Grecka P, Lubos D, Aoun M, Athanassiou K, Bouza E, Devigili E, Krcmery V, Menichetti F, Panaretou E, Papageorgiou E, Plachouras D: Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect 2004; 10: 628-633.
31. Ruokonen E, Nousiainen T, Pulkki K, Takala J: Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis 1999; 18: 283-285.
32. Ortega M, Rovira M, Filella X, Almela M, Puig dlB, Carreras E, Mensa J: Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation. Br J Haematol 2004; 126: 372-376.
33. Hitoglou-Hatzi S, Hatzistilianou M, Gougoustamou D, Rekliti A, Agguridaki C, Athanassiadou F, Frydas S, Kotsis A, Catriu D: Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia. Clin Exp Med 2005; 5: 60-65.
34. Christofilopoulou S, Charvalos E, Petrikkos G: Could procalcitonin be a predictive biological marker in systemic fungal infections? Study of 14 cases. Eur J Intern Med 2002; 13: 493-495.
35. Persson L, Engervall P, Magnuson A, Vikerfors T, Soderquist B, Hansson LO, Tidefelt U: Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004; 36: 365-371.
36. Stryjewski GR, Nylen ES, Bell MJ, Snider RH, Becker KL, Wu A, Lawlor C, Dalton H: Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med 2005; 6: 129-135.
37. Jimeno A, Garcia-Velasco A, del Val O, Gonzalez-Billalabeitia E, Hernando S, Hernandez R, Sanchez-Munoz A, Lopez-Martin A, Duran I, Robles L, Cortes-Funes H, Paz-Ares L: Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 2004; 100: 2462-2469.
38. Fleischhack G, Kambeck I, Cipic D, Hasan C, Bode U: Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II. Br J Haematol 2000; 111: 1093-1102.
39. Schuttrumpf S, Binder L, Hagemann T, Berkovic D, Trumper L, Binder C: Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients? Ann Hematol 2003; 82: 98-103.
40. Giamarellos-Bourboulis EJ, Grecka P, Poulakou G, Anargyrou K, Katsilambros N, Giamarellou H: Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin Infect Dis 2001; 32: 1718-1725.
41. von Lilienfeld-Toal M, Dietrich MP, Glasmacher A, Lehmann L, Breig P, Hahn C, Schmidt-Wolf IG, Marklein G, Schroeder S, Stuber F: Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 2004; 23: 539-544.
42. Kitanovski L, Jazbec J, Hojker S, Gubina M, Derganc M: Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur J Clin Microbiol Infect Dis 2006; 25: 413-415.
43. de Bont ES, Vellenga E, Swaanenburg J, Kamps W: Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever? Infection 2000; 28: 398-400.
44. Secmeer G, Devrim I, Kara A, Ceyhan M, Cengiz B, Kutluk T, Buyukpamukcu M, Yetgin S, Tuncer M, Uludag AK, Tezer H, Yildirim I: Role of procalcitonin and CRP in differentiating a stable from a deteriorating clinical course in pediatric febrile neutropenia. J Pediatr Hematol Oncol 2007; 29: 107-111.
45. Dornbusch HJ, Strenger V, Kerbl R, Lackner H, Schwinger W, Sovinz P, Urban C: Procalcitonin and C-reactive protein do not discriminate between febrile reaction to anti-T-lymphocyte antibodies and Gram-negative sepsis. Bone Marrow Transplant 2003; 32: 941-945.
46. Sauer M, Tiede K, Fuchs D, Gruhn B, Berger D, Zintl F: Procalcitonin, C-reactive protein, and endotoxin after bone marrow transplantation: identification of children at high risk of morbidity and mortality from sepsis. Bone Marrow Transplant 2003; 31: 1137-1142.
47. Ciaccio M, Fugardi G, Titone L, Romano A, Giordano S, Bivona G, Scarlata F, Vocca L, Di Gangi M: Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections. Clin Chim Acta 2004; 340: 149-152.
48. von Lilienfeld-Toal M, Schneider A, Orlopp K, Hahn-Ast C, Glasmacher A, Stuber F: Change of procalcitonin predicts clinical outcome of febrile episodes in patients with hematological malignancies. Support Care Cancer 2006; 14: 1241-1245.
49. Svaldi M, Hirber J, Lanthaler AI, Mayr O, Faes S, Peer E, Mitterer M: Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br J Haematol 2001; 115: 53-57.
50. al Nawas B, Shah PM: Procalcitonin in patients with and without immunosuppression and sepsis. Infection 1996; 24: 434-436.
51. Petrikkos GL, Christofilopoulou SA, Tentolouris NK, Charvalos EA, Kosmidis CJ, Daikos GL: Value of measuring serum procalcitonin, C-reactive protein, and mannan antigens to distinguish fungal from bacterial infections. Eur J Clin Microbiol Infect Dis 2005; 24: 272-275.
52. Gerard Y, Hober D, Petitjean S, Assicot M, Bohuon C, Mouton Y, Wattre P: High serum procalcitonin level in a 4-year-old liver transplant recipient with a disseminated candidiasis. Infection 1995; 23: 310-311.
53. Beaune G, Bienvenu F, Pondarre C, Monneret G, Bienvenu J, Souillet G: Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis. Infection 1998; 26: 168-169.
54. Fraunberger P, Wang Y, Holler E, Parhofer KG, Nagel D, Walli AK, Seidel D: Prognostic value of interleukin 6, procalcitonin, and C-reactive protein levels in intensive care unit patients during first increase of fever. Shock 2006; 26: 10-12.
55. Bodey GP, Buckley M, Sathe YS, Freireich EJ: Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328-340.
56. Dale DC, Guerry D, Wewerka JR, Bull JM, Chusid MJ: Chronic neutropenia. Medicine (Baltimore) 1979; 58: 128-144.
57. Sudhoff T, Giagounidis A, Karthaus M: Serum and plasma parameters in clinical evaluation of neutropenic fever. Antibiot Chemother 2000; 50: 10-19.
58. Lestin F, Lestin HG, Burstein C, Anders O, Freund M: Provisional experience with procalcitonin, C-reactive protein, neopterin, selected cytokines, and hemostatic parameters in patients with malignant hematological diseases and febrile neutropenia induced by cytostatic treatment. Clin Lab 1998; 44: 451-461.
59. Blijlevens NM, Donnelly JP, Meis JF, De Keizer MH, De Pauw BE: Procalcitonin does not discriminate infection from inflammation after allogeneic bone marrow transplantation. Clin Diagn Lab Immunol 2000; 7: 889-892.
60. Erten N, Genc S, Besisik SK, Saka B, Karan MA, Tascioglu C: The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients. J Chin Med Assoc 2004; 67: 217-221.
61. Persson L, Soderquist B, Engervall P, Vikerfors T, Hansson LO, Tidefelt U: Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur J Haematol 2005; 74: 297-303.